Zaid Sadiq1, Stephanie Sammut, Victor Lopes. 1. Combined Department of Oral and Maxillofacial Surgery and Oral Medicine, University of Edinburgh, Lauriston Building, Edinburgh, EH3 9HA, UK, zaidsadiq@nhs.net.
Abstract
OBJECTIVES: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a well-recognised condition that continues to be a therapeutic challenge. It can have devastating effects on patients' quality of life. The literature recommends a myriad of management strategies. This case series demonstrates a combination of resection procedures, local reconstruction options and their impact on quality of life. PATIENTS AND METHODS: This case series consisted of three patients with BRONJ following the use of bisphosphonates (BPs); for metastatic and metabolic bone diseases, none responded to conservative treatment. All patients were surgically managed by a standardised protocol combining bone resection and local reconstructive measures. RESULTS: We evaluated surgery-related change in quality of life using the "University of Washington Quality of Life Questionnaire". At 3 months, all patients were pain free but were only able to manage soft foods and one persisted in using a straw for fluids. In all cases, quality of life scores showed an overall improvement or remained unchanged. There was no evidence of BRONJ recurrence. CONCLUSION: Quality of life is an important consideration in the management of BRONJ patients. Optimal surgical resection and reconstruction may be an ideal treatment plan, but in medically compromised patients, this may not be possible. Consideration should be given to modified strategies with a potentially lower morbidity, yet still aiming to improve patients' quality of life.
OBJECTIVES:Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a well-recognised condition that continues to be a therapeutic challenge. It can have devastating effects on patients' quality of life. The literature recommends a myriad of management strategies. This case series demonstrates a combination of resection procedures, local reconstruction options and their impact on quality of life. PATIENTS AND METHODS: This case series consisted of three patients with BRONJ following the use of bisphosphonates (BPs); for metastatic and metabolic bone diseases, none responded to conservative treatment. All patients were surgically managed by a standardised protocol combining bone resection and local reconstructive measures. RESULTS: We evaluated surgery-related change in quality of life using the "University of Washington Quality of Life Questionnaire". At 3 months, all patients were pain free but were only able to manage soft foods and one persisted in using a straw for fluids. In all cases, quality of life scores showed an overall improvement or remained unchanged. There was no evidence of BRONJ recurrence. CONCLUSION: Quality of life is an important consideration in the management of BRONJ patients. Optimal surgical resection and reconstruction may be an ideal treatment plan, but in medically compromised patients, this may not be possible. Consideration should be given to modified strategies with a potentially lower morbidity, yet still aiming to improve patients' quality of life.
Authors: Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra Journal: J Oral Maxillofac Surg Date: 2009-05 Impact factor: 1.895
Authors: Niall M H McLeod; Vinod Patel; Atul Kusanale; Simon N Rogers; Peter A Brennan Journal: Br J Oral Maxillofac Surg Date: 2010-09-22 Impact factor: 1.651
Authors: Aliya A Khan; George K B Sándor; Edward Dore; Archibald D Morrison; Mazen Alsahli; Faizan Amin; Edmund Peters; David A Hanley; Sultan R Chaudry; David W Dempster; Francis H Glorieux; Alan J Neville; Reena M Talwar; Cameron M Clokie; Majd Al Mardini; Terri Paul; Sundeep Khosla; Robert G Josse; Susan Sutherland; David K Lam; Robert P Carmichael; Nick Blanas; David Kendler; Steven Petak; Louis Georges St-Marie; Jacques Brown; A Wayne Evans; Lorena Rios; Juliet E Compston Journal: J Rheumatol Date: 2008-06-01 Impact factor: 4.666
Authors: Stefan Moll; Steffen Mueller; Johannes K Meier; Torsten E Reichert; Tobias Ettl; Christoph Klingelhöffer Journal: Oral Maxillofac Surg Date: 2020-11-23